Published: 2021-09-28

A study of the knowledge, attitude and behavior among patients with psoriasis vulgaris during the COVID-19 lockdown period

Sukanya G., Richa Jotwani, Manoharan D., Shreya Srinivasan


Background: Patients with psoriasis may have been directly impacted by the COVID-19 lockdown and this may have had a significant effect on disease severity and treatment compliance. This study aims to investigate the knowledge, attitude and the behavioral practices of patients with psoriasis during the lockdown period.

Methods: A self-assessed questionnaire was employed for the purpose of this study and was answered by 100 patients of clinically diagnosed psoriasis.

Results: Although several patients were aware of their condition and its implications, a significant number of responders were found to have a faulty treatment compliance due to the COVID-19 lockdown.

Conclusions: To our knowledge, this is the first study that evaluates the knowledge, attitude and behaviour during the COVID-19 lockdown period of individuals who have been clinically diagnosed with psoriasis. This study raises the possibility that the sustained psychosocial stress induced by the current pandemic can potentially lead to exacerbations or onset of common inflammatory skin conditions like psoriasis. The overall compliance to dermatologic therapy was slightly poor as there were frequent concerns regarding the safety of visiting a hospital or a doctor as well as possible financial constraints. As per this study, there is an urgent need to convey the right information about managing psoriasis during the COVID-19 pandemic among both the general population and patients alike.



Psoriasis, Lockdown, COVID-19

Full Text:



Dalgard FJ, Gieler U, Tomas-Aragones L. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984-91.

Wang Q, Luo Y, Lv C, Zheng X, Zhu W, Chen X et al. Nonadherence to treatment and patient-reported outcomes of psoriasis during the COVID-19 epidemic: a web-based survey. Patient preference adherence. 2020;14:1403

Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20

Gunes AT, Fetil E, Akarsu S, Ozbagcivan O, Babayeva L. Possible triggering effect of influenza vaccination on psoriasis. J Immunol Res. 2015;2015:258430.

Sbidian E, Eftekahri P, Viguier M, Laroche L, Chosidow O, Gosselin P, et al. National survey of psoriasis flares after 2009 monovalent H1N1/seasonal vaccines. Dermatology. 2014;229:130-5.

Choudhry A, Mathena J, Albano JD, Yacovone M, Collins L. Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits. Vaccine. 2016;34:4558-64.

Sterry W, Strober BE, Menter A. International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Bri J Dermatol. 2007;157(4):649-55.

Wolters M. Diet and psoriasis: experimental data and clinical evidence. Bri J Dermatol. 2005;153(4):706-14.

Lourith N, Pungprom S, Kanlayavattanakul M. Formulation and efficacy evaluation of the safe and efficient moisturizing snow mushroom hand sanitizer. J cosmetic dermatol. 2021;20(2):554-60.

Barrea L, Macchia PE, Tarantino G, Di Somma C, Pane E, Balato N, et al. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire. J translational med. 2015;13(1):1-0

Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, et al. National psoriasis foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic. J Am Acad Dermatol. 2020;83(1):1704-16.